FDA fast-tracks psychedelic drug reviews for mental health treatments

Drugs once considered off-limits or dangerous may soon become legitimate in mental health treatments. The FDA is now fast-tracking the review of some psychedelic-based medicines, following a recent executive order from President Donald Trump. Dr. Frank McGeorge gave an update on what that means.